Ads
related to: MERCKsiemens.com has been visited by 10K+ users in the past month
Search results
Merck: Q1 Earnings Snapshot
Houston Chronicle· 22 hours agoRAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 20 hours agoIndustry: Big Pharma Link:...
Scholz Gets Another Pharma Boost With New Merck KGaA Site
Bloomberg· 21 hours agoMerck KGaA became the latest pharma company to begin construction of a new center in Germany,...
Merck hikes outlook for 2024 as Q1 print beats analyst estimates
Investing.com· 1 day agoMerck (MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked...
Merck: Q1 Earnings Snapshot - WTOP News
WTOP Washington· 22 hours agoRAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of…
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 22 hours agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
Merck Raises 2024 Profit Forecast on Strong Sales of Cancer Drug Keytruda
US News & World Report· 22 hours agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous forecast of $8.44 to $8.59, and sales of $63.1-$64.3 billion for the year.
Moderna cancer vaccine offers long-term hope in melanoma
Proactive Investors· 35 minutes agoCovid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III...
Merck stock rises on sales of its blockbuster cancer drug Keytruda
Quartz· 18 hours agoMerck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster ...
